Trans-Tranilast
CAS: 70806-55-2
Ref. TM-T2270
| 5mg | 58.00 € | ||
| 10mg | 94.00 € | ||
| 25mg | 144.00 € | ||
| 50mg | 220.00 € | ||
| 100mg | 330.00 € | ||
| 200mg | 486.00 € | ||
| 500mg | 781.00 € | ||
| 1ml*10 (DMSO) | 63.00 € |
Estimated delivery in United States, on Tuesday 14 May 2024
Product Information
Name:
Trans-Tranilast
Synonyms:
- Tranilast trans-
CAS:
Description:
Trans-Tranilast is an antiallergic drug developed by Kissei Pharmaceuticals. It was approved in 1982 for use in Japan and South Korea for bronchial asthma. Indications for keloid and hypertrophic scar were added in 1993. It has been used for the treatment of allergic disorders such as asthma, allergic rhinitis and atopic dermatitis.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
327.33
Formula:
C18H17NO5
Purity:
99.67%
Color/Form:
Solid
InChI:
InChI=1S/C18H17NO5/c1-23-15-9-7-12(11-16(15)24-2)8-10-17(20)19-14-6-4-3-5-13(14)18(21)22/h3-11H,1-2H3,(H,19,20)(H,21,22)/b10-8+
InChI key:
InChIKey=NZHGWWWHIYHZNX-CSKARUKUSA-N
SMILES:
COc1ccc(/C=C/C(=O)Nc2ccccc2C(=O)O)cc1OC
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T2270 Trans-Tranilast
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
